Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Julian Michael Babarczy currently holds 2,000,000 shares of ALTERITY THERAPEUTICS LTD (ATHE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julian Michael Babarczy has been a net neutral trader of ATHE stock. They have purchased $0 and sold $0 worth of shares.
Julian Michael Babarczy's most recent insider trade was on Jun 15, 2026, when they sold 2,000,000 shares at $0.00 per share.
Julian Michael Babarczy serves as Executive at ALTERITY THERAPEUTICS LTD (ATHE). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Julian Michael Babarczy holds the position of Executive at ALTERITY THERAPEUTICS LTD, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Julian Michael Babarczy has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Julian Michael Babarczy was on Jun 15, 2026, when they purchased $0 worth of ATHE shares. This transaction involved 2,000,000 shares at N/A per share.
Julian Michael Babarczy currently owns 2,000,000 shares of ALTERITY THERAPEUTICS LTD (ATHE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Julian Michael Babarczy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Julian Michael Babarczy has 1 Form 4 filings on record as an insider at ALTERITY THERAPEUTICS LTD.
Set alerts for Julian Michael Babarczy and 40,000+ other insiders.